Related Experiment Video

Updated: Jun 19, 2026

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

THE MECHANISM OF THE CURATIVE ACTION OF ANTIPNEUMOCOCCUS SERUM

C G Bull1

  • 1Laboratories of The Rockefeller Institute for Medical Research.

The Journal of Experimental Medicine
|October 30, 2009
PubMed

Insights

Active antipneumococcus serum rapidly clears pneumococci from rabbit blood by causing bacterial clumping in vivo. This serum demonstrates potent agglutination activity, crucial for treating pneumococcus bacteremia.

Area of Science:

  • Immunology
  • Microbiology
  • Pathology

Background:

  • Pneumococcus infections, such as bacteremia, pose significant health risks.
  • Antipneumococcus serum has been investigated for its therapeutic potential.

Purpose of the Study:

  • To investigate the in vitro and in vivo effects of active antipneumococcus serum on pneumococci.
  • To elucidate the mechanism by which antipneumococcus serum clears pneumococci from the bloodstream.

Main Methods:

  • Microscopic and macroscopic agglutination tests were used to assess serum activity in vitro.
  • Antipneumococcus serum was administered to rabbits with induced pneumococcus bacteremia.
  • Blood samples were analyzed to monitor pneumococcal clearance.

Main Results:

  • The antipneumococcus serum induced rapid agglutination (clumping) of pneumococci in vitro and in vivo.
  • Microscopic tests revealed greater antiserum efficacy at higher dilutions compared to macroscopic tests.
  • In bacteremic rabbits, serum injection led to a swift reduction of pneumococci in the blood.

Conclusions:

  • Active antipneumococcus serum effectively causes pneumococcal agglutination and clearance.
  • In vivo clumping and subsequent organ sequestration (liver, spleen, lungs) mediate bacterial removal.
  • The findings support the therapeutic application of antipneumococcus serum in treating pneumococcus bacteremia.

More Related Videos

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins06:05

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Published on: September 30, 2014

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: